Published May 29, 2025 | Version v1
Project deliverable Open

D3.1 / First report on digital biomarkers for PD

Creators

Contributors

Description

AI-PROGNOSIS aims to develop a system of digital biomarkers for Parkinson’s disease (PD) monitoring and for informing predictive models of disease risk and prognosis. Deliverable D3.1 reports on the development of the first version of digital biomarkers (dBMs) for tracking PD symptoms and risk factors. The focus is placed on motor and non-motor symptoms, including rest tremor, slowness of movement (bradykinesia), dyskinesias, REM Behaviour Disorder (RBD), daytime somnolence, overall physical activity, gross motor function, and cognitive function, using data from wearables, smartphone interaction, and digital active tests.

Files

AI-PROGNOSIS_D3.1 First report on digital biomarkers for PD_v1.0_16122024_withSuppMaterial.pdf

Files (5.7 MB)

Additional details

Funding

European Commission
AI-PROGNOSIS - Artificial intelligence-based Parkinson’s disease risk assessment and prognosis 101080581